74
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Assessment of the effects of glutamic acid decarboxylase antibodies and trace elements on cognitive performance in older adults

, &
Pages 1901-1907 | Published online: 03 Dec 2015

Abstract

Background

Homeostatic imbalance of trace elements such as iron (Fe), copper (Cu), and zinc (Zn) demonstrated adverse effects on brain function among older adults.

Objective

The present study aimed to investigate the effects of trace elements and the presence of anti-glutamic acid decarboxylase antibodies (GADAs) in human cognitive abilities among healthy older adults.

Methods

A total of 100 healthy subjects (65 males, 35 females; age range; 64–96 years) were recruited for this study. Based on Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) score, the participants were classified according to cognitive performance into normal (n=45), moderate (n=30), and severe (n=25). Cognitive functioning, leisure-time physical activity (LTPA), serum trace elements – Fe, Cu, Zn, Zn/Cu, and GADAs were assessed using LOTCA battery, pre-validated physical activity (PA) questionnaire, atomic absorption, and immunoassay techniques, respectively.

Results

Approximately 45% of the study population (n=45) had normal distribution of cognitive function and 55% of the study population (n=55) had abnormal cognitive function; they were classified into moderate (score 62–92) and severe (score 31–62). There was a significant reduction in the level of Zn and Zn/Cu ratio along with an increase in the level of Fe, Cu, and anti-GADAs in subjects of severe (P=0.01) and moderate (P=0.01) cognitive performance. LOTCA-cognitive scores correlated positively with sex, HbA1c, Fe, Cu, Zn, and Zn/Cu ratio, and negatively with age, PA, body mass index, and anti-GADAs. Significant inter-correlation was reported between serum trace element concentrations and anti-GADAs which suggest producing a cognitive decline via oxidative and neural damage mechanism.

Conclusion

This study found significant associations among trace elements, anti-GADAs, and cognitive function in older adults. The homeostatic balance of trace elements should be recommended among older adults for better cognitive performance.

Introduction

Certain cognitive domains and physical inactivity were significantly associated with human aging.Citation1,Citation2 A number of cognitive processes, including attention, learning and memory, and executive control, were changed among older ages.Citation3,Citation4 A decline in cognitive abilities was shown to produce more drastic problems for older adults to perform their daily life activities.Citation5

The severity and prevalence rate of cognitive decline depend mainly on various biological, social, and physiological factors such as lifestyle,Citation6 social network,Citation7,Citation8 and various biomarkers,Citation9 including oxidative stress and free radical damage.Citation10,Citation11 Among these potential markers, trace elements such as iron (Fe), copper (Cu), and zinc (Zn) are biologically essential metals, normally present in the brain.Citation12,Citation13 It was reported that less or excess accumulation of these metals in the brain may cause neurodegenerative disease and cognitive impairment.Citation14Citation16

In older ages, the decline in brain function pathologically attributed with tissue damage, neural cell death,Citation17,Citation18 and significant changes in neural and enzymatic biomarkers such as glutamic acid decarboxylase (GAD),Citation19 which modulates and synchronizes neural network activity in the central nervous system via impairment in the synthesis of γ-aminobutyric acid (GABA). Most research works suggested the association of glutamic acid decarboxylase antibodies (GADAs) in various neurological disorders including cognitive function by affecting the GABAergic system.Citation20,Citation21

Previously, it was reported that cognitive problems may be associated with dysfunction of the GABAergic system.Citation22Citation24 However, it is not known whether cognitive decline appears as a result of neurological changes in the central nervous system associated with anti-GAD antibodies and/or trace elements. So, to study the role of anti-GAD antibodies and trace elements Fe, Cu, and Zn as risk factors in human cognitive abilities, we assessed these parameters and its association with cognitive function in healthy older adults.

Materials and methods

Subjects

A total of 350 healthy subjects were subjected to randomized electoral roll selection. Out of them, only 100 healthy subjects (65 males, 35 females), aged 64–96 years with a mean age of 65.2±3.6 years, randomly participated in this study (). Subjects with endocrine, immune, psychiatric illness, eating disorders, and taking glucocorticoid medication that could interfere with cognitive ability measurements were excluded from this study. Based on the Loewenstein Occupational Therapy Cognitive Assessment (LOTCA) score, participants were classified according to their cognitive performance into normal (93–123; n=45), moderate (62–92; n=30), and severe (31–62; n=25). Standardized measures of weight and height were taken in light clothing and body mass index (BMI; in kg/m2) was calculated. All study participants gave informed consent prior to inclusion. This study was approved by ethical committee of Rehabilitation Research Chair of King Saud University, under file number (RRC-2014-016).

Table 1 General characteristics of subjects

Assessment of cognitive abilities

Instrument

Trained research assistants assessed the cognitive abilities of older adult’s pre- and post-supervised aerobic exercise using the LOTCA battery. Assessments required between 45 and 90 minutes. The LOTCA consists of seven major domains divided into 26 subtests, with each subtest scored on a 4- or 5-point Likert scale. The assessment of LOTCA test was performed according to instruction manuals as reported in the literature.Citation25

Results are presented as a profile along all subtests. A composite score for each domain was calculated by summing the scores of the relevant subtests. The LOTCA score was calculated by summing the score of all subtests. The maximum score on the test is 123 and the minimum score is 27. A higher score indicates a better cognitive performance. Based on the LOTCA score, the cognitive performance of participants was classified into nrmal (93–123; n=45), moderate (62–92; n=30), and severe (31–62; n=25).

LOTCA test validity

The test has excellent intra-rater reliability (100%), and good inter-rater reliability (86%) as well as criterion validity (78%).Citation26 This LOTCA test was chosen because of its psychometric properties and primarily non-verbal nature, making it potentially more suitable for evaluating the cognitive abilities of individuals from non-Western and non-English-speaking cultures. Several studies have been conducted using this instrument in both WesternCitation26 and Arab populations.Citation2

Assessment of physical activity

Physical activity of the participants was assessed in relation to the time spent in performing moderate and intense exercise programs. The activity denoted as leisure-time physical activity (LTPA) was measured by metabolic equivalents as previously reported.Citation27,Citation28

Assessment of anti-GADAs

Serum anti-GAD antibody titers were measured using a commercially available ELISA kit (RSR cat GDE96, RSR Limited, Cardiff, UK), which provides a specific and sensitive method for evaluating GAD antibodies.

Assessment of serum trace elements

Levels of Fe, Cu, and Zn in the sera were determined using an atomic absorption spectrophotometer device (Varian AA240FS Model, Varian Inc., Belrose, Australia). The measurements were conducted twice for each sample, using light at 2,139 wavelength according to a flame atomization method. Levels of serum Fe, Cu, and Zn were determined as µg/dL.

Statistical analysis

Descriptive statistics were expressed as mean and standard deviation. Student’s t-test was used to compare groups. Spearman’s correlations were used to assess correlations between cognitive performance score and related biochemical and demographic factors. P-values <0.05 were considered to be significant. Statistical analysis was performed using SPSS version 17.

Results

A total of 100 healthy subjects aged 64–96 years were subjected for cognitive ability measurements and estimation of biochemical related factors. Most of subjects (80%) participated in these study had attended some college or more. Statistical significant analysis of other demographic and cognitive function parameters is shown in . According to cognitive ability measurements, approximately 45% of the study population (n=45) had normal distribution of cognitive function with 111.2 mean LOTCA-7 score, and 55% of the study population (n=55) had abnormal cognitive function; they were classified into moderate (score 62–92), and severe (score 31–62) ().

Table 2 Cognitive performance in the studies population based on LOTCA-7 scores (n=100)

As shown, a significant increase in BMI (P=0.05), waist to hip ratio (WHR) (P=0.05), and glycemic control parameter; HbA1c (P=0.01) was reported in participants with abnormally distributed cognitive function as was the lack of physical fitness measured by leisure-time physical activity (LTPA) (P=0.01) as shown in .

Table 3 Associations of serum trace elements, HbA1c, BMI, WHR, and anti-GADAs titers with cognitive performance of older adults (n=100)

The results showed a statistically significant difference in the level of serum concentrations of trace elements, anti-GADAs, and HbA1c%. There was a significant reduction in the level of Zn and Zn/Cu ratio along with an increase in the level of Fe, Cu, anti-GADAs, and HbA1c% in subjects of severe (P=0.01) and moderate (P=0.01) cognitive performance compared to normal control group ().

Based on the presence of anti-GADAs, the data obtained showed a significant reduction (P=0.01) in serum concentrations of Zn and Zn/Cu ratio along with a significant increase in the level of serum Cu, Fe, and HbA1c% in subjects with positive anti-GADAs compared to control negative cases as shown in .

Table 4 Serum trace elements concentrations in studied population based on anti-GADAs titers (n=100)

Correlation coefficients of the studied independent factors were estimated using a stepwise regression analysis. There was significant correlation among serum concentrations of trace elements, BMI, PA status, HbA1c, anti-GADAs, and LOTCA-cognitive score analyses in older adults. LOTCA-cognitive scores correlated positively with sex, HbA1c, trace elements; Fe, Cu, Zn, Zn/Cu ratio and negatively with age, PA, BMI, and anti-GADAs as shown in and .

Table 5 Results of stepwise multiple regression analysis of cognitive ability predicted by serum trace elements, and anti-GADAs, and demographic related variables

Table 6 Correlation of LOTCA cognitive function scores with serum trace elements, and anti-GADAs of older adults (n=100)

Discussion

More than 20% of cognitive decline was reported in older adults.Citation29,Citation30 Many research studies supported that age-related cognitive impairment may be associated with many demographic, physiological, and modifiable risk factors.Citation8,Citation9,Citation31,Citation32

The present study aimed to investigate the effects of trace elements and the presence of anti-GADAs in human recognition among healthy older adults.

In the present study, approximately 45% of participants had a normal distribution of cognitive function with 111.2 mean LOTCA-7 score and 55% of participants had abnormal scores of cognitive performance; they were classified into moderate (score 62–92; 30%), and severe (score 31–62; 25%).

There was statistical significant variability in the studied cognitive parameters such as motor praxis, vasomotor organization, thinking operations, attention, and concentration in older adults with moderate or severe cognitive impairment. Also, there was significant correlation among age, sex, HbA1c, BMI, PA status, and LOTCA-7 score in all stages of cognitive performance. LOTCA-7 cognitive score variables correlated positively with sex, HbA1c and negatively with age, BMI, WHR, and PA in participants with moderate and severe cognitive disorders compared with the control group. Previous research reports suggested the influence of life style and demographic parameters on cognitive function in older adults, whereas more than 20% of adult populations were suffering from cognitive disorder.Citation30,Citation33,Citation34 Also, several research studies reported positive effects of physical activity on cognitive performance scores among older adults.Citation2,Citation35 In a study, Dunton et alCitation36 reported improvement of cognitive function in older adults following physical activity. In the same manner, our results were inconsistent with other studies showing that the beneficial effects of PA in reducing the risks of cognitive impairment,Citation37,Citation38 as well as better processing speed, memory, and executive function.Citation38 In agreement with other studies, our results showed that obesity-related variables and higher level of HbA1c were associated with a significant degree of cognitive decline among older adults.Citation39Citation41

In addition, other studies revealed correlation among age, sex, lack of physical activity, higher BMI, and the coexistence of depression and cognitive disorders.Citation42Citation46

In the present study, there was a significant increase in the level of anti-GADAs in participants with a moderate and severe decline of cognitive function compared to healthy group. The results showed that LOTCA-cognitive scores correlated negatively with anti-GADAs in the participants with abnormal cognitive function.

The results of our study matched with other studies that reported the association of GADAs with various neurological disorders including cognitive function by affecting the GABAergic system.Citation20,Citation21 Similarly, Saidha et alCitation23 and Black et alCitation24 reported that cognitive problems may be associated with dysfunction of the GABAergic system.

Recently, it was reported that higher anti-GAD antibody levels are significantly related to more neurological disorders via stimulating anti-GAD autoimmunity which considers the potential cause of the cerebral involvement and cognitive decline.Citation20,Citation47

There was a significant association between trace elements and cognitive function in older adults of the present study. Participants with moderate and severe cognitive disorders showed significantly different concentrations of Fe, Cu, and Zn and different patterns of associations between these minerals and cognitive function scores. Analyses using trace minerals as continuous variables showed that higher concentrations of Fe, Cu, and lower concentrations of Zn and Zn/Cu ratio were greatly associated with poorer cognitive performance on tests of long-term memory, motor praxis, and vasomotor organization, thinking operations, attention and concentration compared to intermediate concentrations.

In previous study, positive relationship between cognitive function and dietary intake of Zn and Fe was reported among healthy elderly adults.Citation48 In addition, copper intake was found to be a risk factor for cognitive decline in persons with high-saturated and trans-fat levels.Citation49

Previous finding supported the association of plasma copper and cognitive score among elderly people of our study.Citation50 The severity of copper on cognition depends on oxidative stress and neurotoxicity mechanism,Citation51 especially in individuals with high-saturated or trans-fat levels.Citation48,Citation52

The homeostatic balance of Fe, Cu, and Zn is essential for optimized brain function.Citation53,Citation54 Whereas, the lower change in the levels of these mineral effects on cognitive abilities via poor neurotransmission,Citation55,Citation56 and impair neuropsychological function,Citation57 and that higher levels produce impairment of brain function via oxidative stress and neuro-degeneration processes.Citation53,Citation58

In addition, Faber et alCitation59 reported that the change in Zn and Cu is inversely related and the normal Zn-to-Cu ratio in children and adults is close to 1:1. In our study, a significant decrease in the Zn-to-Cu ratio was reported in participants with poorer cognitive performance. The lower Zn/Cu ratios may reflect total body Zn deficiency or accumulation of Zn-antagonistic toxic metals which effects on the metal-lothionein system.Citation60

In the present study, there was a significant correlation between Fe, Cu, Zn concentrations and the level of anti-GA-DAs in participants with poorer cognitive performance. The increase in Cu and Fe levels is attributed with a significant increase in anti-GADAs which reflects the inhibition rate of GAD enzyme via oxidative stress mechanism including hydroxyl radicals.Citation61 Also, it was reported that copper plays a significant role in oxidative attack on GAD enzyme through Fenton-like reactions.Citation62,Citation63

Conclusion

This study found significant associations among trace elements, anti-GADAs, and cognitive function in older adults. The homeostatic balance of trace elements should be recommended among older adults for better cognitive performance.

Acknowledgments

The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this research through the research group No RGP-VPP-209.

Disclosure

The authors report no conflicts of interest in this work.

References

  • MiddletonLEBarnesDELuiLYaffeKPhysical activity over the life course and its association with cognitive performance and impairment in old ageJ Am Geriatr Soc20105871322132620609030
  • JosmanNAbdallahTMEngel-YegerBUsing the LOTCA to measure cultural and sociodemographic effects on cognitive skills in two groups of childrenAm J Occup Ther201165293721309369
  • GradyCThe cognitive neuroscience of ageingNat Rev Neurosci201213749150522714020
  • AlbertMSDeKoskySTDicksonDThe diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the national institute on aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimer’s Dement20117327027921514249
  • RoyallDRPalmerRChiodoLKPolkMJNormal rates of cognitive change in successful aging: the freedom house studyJ Int Neuropsychol Soc20051189990916519269
  • Stine-MorrowEALParisiJMMorrowDGParkDCThe effects of an engaged lifestyle on cognitive vitality: a field experimentPsychol Aging200823477878619140649
  • AttiARForlaniCDe RonchiDPalmerKCasadioPDalmonteECognitive impairment after age 60: clinical and social correlates in the “Faenza Project”J Alzheimer’s Dis20102141325133421504137
  • WhitsonHEAnsahDWhitakerDPrevalence and patterns of comorbid cognitive impairment in low vision rehabilitation for macular diseaseArch Gerontol Geriatr201050220921219427045
  • SongFPoljakASmytheGASachdevPPlasma biomarkers for mild cognitive impairment and Alzheimer’s diseaseBrain Res Rev2009612698019464319
  • LovellMAMarkesberyWROxidative DNA damage in mild cognitive impairment and late-stage Alzheimer’s diseaseNucleic Acids Res20073522749750417947327
  • ButterfieldDASultanaRRedox proteomics identification of oxida-tively modified brain proteins in Alzheimer’s disease and mild cognitive impairment: insights into the progression of this dementing disorderJ Alzheimer’s Dis2007121617217851195
  • PraticoDAlzheimer’s disease and oxygen radicals: new insightsBiochem Pharmacol20026356356711992623
  • DosunmuRWuJBashaMRZawiaNHEnvironmental and dietary risk factors in Alzheimer’s diseaseExpert Rev Neurotherap200777887900
  • SilvestriLCamaschellaCApotential pathogenetic role of iron in Alzeimer’s DiseaseJ Cell Mol Med200851
  • LauFCShukitt-HaleBJosephJANutritional intervention in brain aging: reducing the effects of inflammation and oxidative stressSubcell Biochem20074229931817612057
  • ColeGMLimGPYangFPrevention of Alzheimer’s disease: Omega-3 fatty acid and phenolic anti-oxidant interventionsNeurobiol Aging200526Suppl 113313616266772
  • GardeEMortensenELKrabbeKRostrupELarssonHBWRelation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal studyLancet200035662863410968435
  • De GrootJCDe LeeuwFEOudkerkMGijnJVHofmanAJollesJPeriventricular cerebral white matter lesions predict rate of cognitive declineAnn Neurol20025233534112205646
  • CobbSRBuhlEHHalasyKPaulsenOSomogyiPSynchronization of neuronal activity in hippocampus by individual GABAergic interneuronsNature199537875787477292
  • SaizABlancoYSabaterLSpectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this associationBrain20081312553256318687732
  • AliFRowleyMJayakrishnanBTeuberSGershwinMEMackayIRStiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathiesJ Autoimmun201137798721680149
  • TinsleyJABarthEMBlackJLWilliamsDEPsychiatric consultations in stiff-man syndromeJ Clin Psychiatry1997584444499375596
  • SaidhaSMurphySRonayneAMcCarthyPHennessyMJCounihanTTreatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetilJ Neurol20102571035103820130897
  • BlackJLBarthEMWilliamsDETinsleyJAStiff-man syndrome. Results of interviews and psychologic testingPsychosomatics19983938449538674
  • AlmomaniFJosmanNAlmomaniMOFactors related to cognitive function among elementary school childrenScand J Occup Ther20142119119824215566
  • ItzkovichMElazarBAverbuchSLoewenstein Occupational Therapy Cognitive Assessment (LOTCA) manual2nd ed Printed in USAOccupational Therapy Department, Loewenstein Rehabilitation Hospital, IsraelMaddac2000
  • BullFCMaslinTSArmstrongTGlobal physical activity questionnaire (GPAQ): nine country reliability and validity studyJ Phys Act Health2009679080420101923
  • TrinhOTHNguyenNDvan der PloegHPDibleyMJBaumanATest-retest repeatability and relative validity of the Global Physical Activity Questionnaire in a developing country contextJ Phys Act Health20096S46S5319998849
  • SchroderJKratzBPantelJMinnemannELehrUSauerHPrevalence of mild cognitive impairment in an elderly community sampleJ Neural Transm Suppl19985451599850914
  • UnverzagtFWGaoSBaiyewuOPrevalence of cognitive impairment: data from the Indianapolis Study of Health and AgingNeurology2001571655166211706107
  • VellasBLauqueSAndrieuSNutrition assessment in the elderlyCurr Opin Clin Nutr Metab Care200145811122552
  • EkmekciogluCThe role of trace elements for the health of elderly individualsNahrung20014530931611715341
  • GlymourMMManlyJJLifecourse social conditions and racial and ethnic patterns of cognitive agingNeuropsychol Rev20081822325410.1007/s11065-008-9064-z18815889
  • Zeki Al HazzouriAHaanMNOsypukTAbdouCHintonLAielloAENeighborhood socioeconomic context and cognitive decline among older Mexican Americans: results from the Sacramento Area Latino Study on AgingAm J Epidemiol201117442343121715645
  • ArcherTGarciaDPhysical exercise influences academic performance and well-being in children and adolescentsInt J School Cogn Psychol20141e102
  • DuntonGFHuhJLeventhalAMMomentary assessment of affect, physical feeling states, and physical activity in childrenHealth Psychol201433325526323668846
  • WoodardJLSugarmanMANielsonKALifestyle and genetic contributions to cognitive decline and hippocampal structure and function in healthy agingCurr Alzheimer Res20129443644622272622
  • ChangYKNienYHTasiCLEtnierJLPhysical activity and cognition in older adults: the potential of Tai Chi ChuanJ Aging Phys Activity201018451472
  • JacobsonAMMusenGRyanCMLong-term effect of diabetes and its treatment on cognitive functionNew Engl J Med2007356181842185217476010
  • Cukierman-YaffeTGersteinHCWilliamsonJDRelationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factorsDiabetes Care200932222122619171735
  • ReijmerYDvan den BergERuisCKappelleLJBiesselsGJCognitive dysfunction in patients with type 2 diabetesDiabetes/Metab Res Rev2010267507519
  • PizziCManzoliLManciniSCostaGMAnalysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability, markers of inflammation, and endothelial functionEur Heart J20082991110111718400765
  • SweilehWMAbu-HadeedHMAl-JabiSWZyoudSHPrevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in PalestineBMC Public Health201414116324524353
  • MaylorEAReimersSChoiJCollaerMLPetersMSilvermanIGender and sexual orientation differences in cognition across adulthood: age is kinder to women than to men regardless of sexual orientationArch Sex Behav200736223524917351741
  • TripathiRKumarKBharathSMarimuthuPVargheseMAge, education and gender effects on neuropsychological functions in healthy Indian older adultsDement Neuropsychol201482148154
  • PetersenRCRobertsROKnopmanDSPrevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of AgingNeurology2010751088989720820000
  • DalakasMCLiMFujiiMJacobowitzDMStiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodiesNeurology20015778078411552003
  • OrtegaRMRequejoAMAndresPDietary intake and cognitive function in a group of elderly peopleAm J Clin Nutr1997668038099322553
  • MorrisMCEvansDATangneyCCDietary copper and high saturated and trans fat intakes associated with cognitive declineArch Neurol2006631085108816908733
  • SquittiRBarbatiGRossiLExcess of non ceruloplasmin serum copper in AD correlates with MMSE, CSF (beta)-amyloid, and h-tauNeurology200667768216832081
  • HuangXCuajungcoMPAtwoodCSCu(II) potentiation of Alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reductionJ Biol Chem1999274371113711610601271
  • SquittiRRossiniPMCassettaED-penicillamine reduces serum oxidative stress in Alzheimer’s disease patientsEur J Clin Invest200232515911851727
  • CuajungcoMPFagetKYZinc takes the center stage: its paradoxical role in Alzheimer’s diseaseBrain Res Brain Res Rev200341445612505647
  • ThompsonKJShohamSConnorJRIron and neurodegenerative disordersBrain Res Bull20015515516411470311
  • YoudimMBBen ShacharDRiedererPIron in brain function and dysfunction with emphasis on Parkinson’s diseaseEur Neurol199131Suppl 134401649757
  • TurnlundJRCopperShilsMModern Nutrition in Health and DiseaseBaltimoreWilliams & Wilkins1999241252
  • SandsteadHHFredericksonCJPenlandJGHistory of zinc as related to brain functionJ Nutr2000130496S502S10721938
  • SquittiRLupoiDPasqualettiPElevation of serum copper levels in Alzheimer’s diseaseNeurology2002591153116112391342
  • FaberSZinnGMKernJC2ndKingstonHMThe plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disordersBiomarkers20091417118019280374
  • AschnerMSyversenTSouzaDORochaJBTMetallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicityExp Biol Med200623114681473
  • KhanMWSherwaniSKhanWAAliRCharacterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetesAutoimmunity20094215015819085183
  • LiQGuoMXuXRapid decrease of GAD 67 content before the convulsion induced by hyperbaric oxygen exposureNeurochem Res20083318519317712632
  • TrigwellSMRadfordPMPageSRIslet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitusClin Exp Immunol200112624224911703367